Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
A joint report published in June 2025 by the European Respiratory Society and WHO/Europe noted that 81.7 million people in the WHO European Region suffer from chronic respiratory illnesses, highlighting a massive demographic in need of oxygen saturation tracking. Despite this strong demand, market growth faces a notable hurdle due to proven variations in pulse oximeter precision across different skin tones. This unreliability can result in delayed medical care or inaccurate diagnoses for certain demographics.
Market Driver
A major catalyst for the worldwide pulse oximeter industry is the escalating incidence of respiratory illnesses, which makes the continuous tracking of blood oxygen levels essential. Respiratory issues like asthma and chronic obstructive pulmonary disease demand regular evaluation to control the illness's advancement and avoid severe flare-ups. A January 2026 study in Nature Medicine revealed that roughly 570 million individuals globally lived with chronic respiratory conditions in 2023, highlighting a massive patient base that needs monitoring equipment such as pulse oximeters. This extensive health burden creates a strong necessity for both patients and medical systems to utilize reliable, non-invasive tracking methods.Market growth is additionally fueled by the expanding elderly demographic and their related chronic diseases. Seniors face a higher risk of developing age-linked issues such as diabetes, cardiovascular disorders, and respiratory problems, all of which routinely require ongoing physiological tracking. An October 2025 report from the World Economic Forum estimates that the global population aged 60 and older will climb from 1.1 billion in 2023 to 1.4 billion by 2030, creating an expanding group that often depends on home monitoring and extended care. This shifting demographic fuels the need for easy-to-use, portable pulse oximeters for remote health management, a trend supported by global hospitals purchasing more than 36 million reprocessed single-use tools, including oximeter sensors, from Association of Medical Device Reprocessors members in 2024.
Market Challenge
A major obstacle to the growth of the worldwide pulse oximeter industry is the proven unreliability of these devices across varying skin tones. This issue diminishes the dependability of the equipment and generates skepticism among both medical practitioners and patients, especially within multicultural populations. If oximeters yield incorrect measurements for specific skin colors, it raises the danger of delayed treatments or incorrect diagnoses, ultimately threatening patient safety and eroding trust in the technology's overall capability.This problem actively restricts market expansion by triggering stricter regulatory oversight and potentially driving up production expenses as companies strive to meet tougher testing standards. In January 2025, the U.S. Food and Drug Administration (FDA) issued draft guidelines advising producers to expand their testing groups from a minimum of 10 people to 150, ensuring that at least 25% of the subjects possess darker skin. This updated regulatory stance underscores the critical nature of the issue, showing that prior testing methods were inadequate and forcing manufacturers to invest heavily to verify device accuracy across a more diverse demographic, thereby complicating market entry and slowing product innovation.
Market Trends
A prominent trend in the industry is the shrinking size of pulse oximeters and the surge in wearable health technology, moving patient monitoring out of hospitals and into daily routines. These small, discreet tools are now built into everyday items such as smartwatches and rings, allowing for seamless and ongoing monitoring of pulse rates and SpO2 levels. Such easy access promotes preventative health tracking and the swift identification of oxygen drops outside of medical facilities, greatly improving patient compliance and involvement. This shift highlights a rising consumer desire for continuous, integrated health data, as supported by Philips' February 2026 annual report showing a 7% rise in Connected Care comparable sales during the final quarter of 2025, demonstrating the growing embrace of personal health tracking technologies.A further critical development is the rise of AI-enhanced and smart oximetry, transforming basic measuring devices into advanced predictive and diagnostic systems. By incorporating artificial intelligence, pulse oximeters can now evaluate complex physiological data, identify minor irregularities, and deliver predictive analysis regarding a patient's respiratory health. These smart tools also minimize false alerts and enhance data comprehension, resulting in more streamlined medical responses. These upgrades are vital for refining diagnostic precision and customizing treatment, especially during continuous remote tracking or intricate medical situations, a trend mirrored by GE HealthCare's dedication of over USD 1.7 billion to innovation in 2025, encompassing AI-powered monitoring and diagnostic advancements.
Key Market Players
- Medtronic Plc.
- GE Healthcare
- Koninklijke Philips N.V.
- Masimo Corporation
- Nihon Kohden Corporation
- Nonin Medical Inc.
- Omron Corporation
- Opto Circuits India Ltd.
- Welch Allyn Inc.
- OSI SystemsInc.
Report Scope
In this report, the Global Pulse Oximeter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Pulse Oximeter Market, By Product Type:
- Fingertip
- Handheld
- Others
Pulse Oximeter Market, By Sensor Type:
- Reusable
- Disposable
Pulse Oximeter Market, By Patient Type:
- Adult
- Pediatric
- Neonatal
Pulse Oximeter Market, By End User:
- Hospitals & Clinics
- Homecare
- Others
Pulse Oximeter Market, By Region:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Pulse Oximeter Market .Available Customizations
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Medtronic Plc.
- GE Healthcare
- Koninklijke Philips N.V.
- Masimo Corporation
- Nihon Kohden Corporation
- Nonin Medical Inc.
- Omron Corporation
- Opto Circuits India Ltd.
- Welch Allyn Inc.
- OSI SystemsInc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | May 2026 |
| Forecast Period | 2025 - 2031 |
| Estimated Market Value ( USD | $ 4.05 Billion |
| Forecasted Market Value ( USD | $ 5.71 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |


